Radionuclide evaluation of CHF.
D000293:Adolescent; D000328:Adult; D003327:Coronary Disease / Q000000981:diagnostic imaging; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D006322:Heart Aneurysm / Q000000981:diagnostic imaging; D006333:Heart Failure / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D005996:Nitroglycerin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011877:Radionuclide Imaging; D013667:Technetium; D013806:Theophylline / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D004077:Digoxin; D013667:Technetium; D011433:Propranolol; D013806:Theophylline; D014700:Verapamil; D005996:Nitroglycerin